Mary Fruciano

1.1k total citations
23 papers, 857 citations indexed

About

Mary Fruciano is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Mary Fruciano has authored 23 papers receiving a total of 857 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Physiology. Recurrent topics in Mary Fruciano's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Cellular Mechanics and Interactions (4 papers) and Systemic Sclerosis and Related Diseases (3 papers). Mary Fruciano is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Cellular Mechanics and Interactions (4 papers) and Systemic Sclerosis and Related Diseases (3 papers). Mary Fruciano collaborates with scholars based in Italy, Japan and Germany. Mary Fruciano's co-authors include Carlo Vancheri, Evelina Fagone, Elisa Gili, Enrico Conte, Maria Iemmolo, Nunzio Crimi, Salvatore Cuzzocrea, Filippo Caraci, Tiziana Genovese and Rosario Giuffrida and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Annals of the New York Academy of Sciences.

In The Last Decade

Mary Fruciano

23 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary Fruciano Italy 16 483 230 151 84 78 23 857
Evelina Fagone Italy 16 606 1.3× 251 1.1× 149 1.0× 91 1.1× 90 1.2× 25 973
Elisa Gili Italy 20 667 1.4× 411 1.8× 185 1.2× 125 1.5× 94 1.2× 32 1.3k
Yoshiaki Hagiwara Japan 17 281 0.6× 294 1.3× 75 0.5× 115 1.4× 97 1.2× 35 924
Chao He United States 18 484 1.0× 350 1.5× 85 0.6× 56 0.7× 41 0.5× 39 1.0k
Dingyuan Jiang China 15 350 0.7× 374 1.6× 105 0.7× 59 0.7× 25 0.3× 31 854
Deepali Kurundkar United States 12 783 1.6× 526 2.3× 220 1.5× 144 1.7× 65 0.8× 12 1.5k
Yilin Zhao China 14 184 0.4× 329 1.4× 102 0.7× 91 1.1× 43 0.6× 19 681
Hiroshi Mochimaru Japan 15 169 0.3× 209 0.9× 67 0.4× 118 1.4× 52 0.7× 25 748
Reinhard Pregla Germany 18 191 0.4× 471 2.0× 91 0.6× 76 0.9× 27 0.3× 30 1.2k
Wouter Peeters Netherlands 14 313 0.6× 292 1.3× 92 0.6× 48 0.6× 36 0.5× 22 948

Countries citing papers authored by Mary Fruciano

Since Specialization
Citations

This map shows the geographic impact of Mary Fruciano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Fruciano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Fruciano more than expected).

Fields of papers citing papers by Mary Fruciano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Fruciano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Fruciano. The network helps show where Mary Fruciano may publish in the future.

Co-authorship network of co-authors of Mary Fruciano

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Fruciano. A scholar is included among the top collaborators of Mary Fruciano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Fruciano. Mary Fruciano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vancheri, Carlo, Lucia Spicuzza, Mary Fruciano, et al.. (2024). Pharmacological treatment in Idiopathic Pulmonary Fibrosis: current issues and future perspectives. Multidisciplinary Respiratory Medicine. 19(Vol. 19 (2024)). 1 indexed citations
2.
Spicuzza, Lucia, Stefano Palmucci, Evelina Fagone, et al.. (2023). Clinical and Prognostic Significance of p-ANCA Positivity in Idiopathic Pulmonary Fibrosis: A Retrospective Observational Study. Diagnostics. 13(11). 1882–1882. 5 indexed citations
3.
Sambataro, Gianluca, Martina Orlandi, Evelina Fagone, et al.. (2023). Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study. Biomedicines. 11(3). 658–658. 2 indexed citations
4.
Fagone, Evelina, Mary Fruciano, Elisa Gili, Gianluca Sambataro, & Carlo Vancheri. (2022). Developing PI3K Inhibitors for Respiratory Diseases. Current topics in microbiology and immunology. 436. 437–466. 2 indexed citations
5.
Spampinato, Simona Federica, Sara Merlo, Evelina Fagone, et al.. (2020). Reciprocal Interplay Between Astrocytes and CD4+ Cells Affects Blood-Brain Barrier and Neuronal Function in Response to β Amyloid. Frontiers in Molecular Neuroscience. 13. 120–120. 16 indexed citations
6.
Spampinato, Simona Federica, Sara Merlo, Evelina Fagone, et al.. (2019). Astrocytes Modify Migration of PBMCs Induced by β-Amyloid in a Blood-Brain Barrier in vitro Model. Frontiers in Cellular Neuroscience. 13. 337–337. 20 indexed citations
7.
Conte, Enrico, Evelina Fagone, Elisa Gili, et al.. (2016). Preventive and therapeutic effects of thymosin β4 N-terminal fragment Ac-SDKP in the bleomycin model of pulmonary fibrosis. Oncotarget. 7(23). 33841–33854. 17 indexed citations
8.
Conte, Enrico, Maria Iemmolo, Mary Fruciano, et al.. (2015). Effects of thymosin β4 and its N-terminal fragment Ac-SDKP on TGF-β-treated human lung fibroblasts and in the mouse model of bleomycin-induced lung fibrosis. Expert Opinion on Biological Therapy. 15(sup1). 211–221. 15 indexed citations
9.
Conte, Enrico, Evelina Fagone, Mary Fruciano, et al.. (2015). Anti-inflammatory and antifibrotic effects of resveratrol in the lung.. PubMed. 30(5). 523–9. 40 indexed citations
10.
Conte, Enrico, Mary Fruciano, Elisa Gili, et al.. (2014). Molecular mechanisms of pirfenidone activity in human lung fibroblasts. European Respiratory Journal. 44(Suppl 58). P825–P825. 4 indexed citations
11.
Conte, Enrico, Maria Iemmolo, Evelina Fagone, et al.. (2014). Thymosin β4 reduces IL-17-producing cells and IL-17 expression, and protects lungs from damage in bleomycin-treated mice. Immunobiology. 219(6). 425–431. 21 indexed citations
12.
Conte, Enrico, Elisa Gili, Evelina Fagone, et al.. (2014). Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts. European Journal of Pharmaceutical Sciences. 58. 13–19. 281 indexed citations
13.
Conte, Enrico, Elisa Gili, Mary Fruciano, Evelina Fagone, & Carlo Vancheri. (2013). Human lung fibroblasts increase CD4(+)CD25(+)Foxp3(+) T cells in co-cultured CD4(+) lymphocytes. Cellular Immunology. 285(1-2). 55–61. 4 indexed citations
14.
Conte, Enrico, Elisa Gili, Mary Fruciano, et al.. (2013). PI3K p110γ overexpression in idiopathic pulmonary fibrosis lung tissue and fibroblast cells: in vitro effects of its inhibition. Laboratory Investigation. 93(5). 566–576. 76 indexed citations
15.
Conte, Enrico, Tiziana Genovese, Elisa Gili, et al.. (2012). Thymosin β4 protects C57BL/6 mice from bleomycin‐induced damage in the lung. European Journal of Clinical Investigation. 43(3). 309–315. 25 indexed citations
16.
Conte, Enrico, Tiziana Genovese, Elisa Gili, et al.. (2012). Protective effects of thymosin β4 in a mouse model of lung fibrosis. Annals of the New York Academy of Sciences. 1269(1). 69–73. 15 indexed citations
17.
Conte, Enrico, Mary Fruciano, Evelina Fagone, et al.. (2011). Inhibition of PI3K Prevents the Proliferation and Differentiation of Human Lung Fibroblasts into Myofibroblasts: The Role of Class I P110 Isoforms. PLoS ONE. 6(10). e24663–e24663. 125 indexed citations
18.
19.
Failla, Marco, Tiziana Genovese, Emanuela Mazzon, et al.. (2008). 16,16-Dimethyl Prostaglandin E2 Efficacy on Prevention and Protection from Bleomycin-Induced Lung Injury and Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 41(1). 50–58. 32 indexed citations
20.
Cuzzocrea, Salvatore, Tiziana Genovese, Marco Failla, et al.. (2007). Protective effect of orally administered carnosine on bleomycin-induced lung injury. American Journal of Physiology-Lung Cellular and Molecular Physiology. 292(5). L1095–L1104. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Evelina Fagone Breakdown of academic impact, for papers by Elisa Gili Breakdown of academic impact, for papers by Yoshiaki Hagiwara Breakdown of academic impact, for papers by Chao He Breakdown of academic impact, for papers by Dingyuan Jiang Breakdown of academic impact, for papers by Deepali Kurundkar Breakdown of academic impact, for papers by Yilin Zhao Breakdown of academic impact, for papers by Hiroshi Mochimaru Breakdown of academic impact, for papers by Reinhard Pregla Breakdown of academic impact, for papers by Wouter Peeters
Rankless by CCL
2026